Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 2, 2020

Primary Completion Date

December 18, 2023

Study Completion Date

December 18, 2023

Conditions
Invasive Aspergillosis
Interventions
DRUG

Posaconazole IV

Posaconazole (POS) 6 mg/kg body weight by IV infusion

DRUG

Posaconazole PFS

Dosing based on weight-band taken orally

DRUG

Posaconazole tablet

POS tablet 300 mg taken orally

Trial Locations (29)

1089

Heim Pal Orszagos Gyermekgyogyaszati Intezet ( Site 1103), Budapest

1097

Del-pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet ( Site 1102), Budapest

1200

UCL St Luc ( Site 1000), Brussels

3000

UZ Leuven ( Site 1001), Leuven

3526

BAZ Megyei Korhaz. Klinikai Onkologia es Sugarterapias Centrum ( Site 1101), Miskolc

9000

UZ Gent ( Site 1002), Ghent

10126

Ospedale Regina Margherita ( Site 1150), Torino

15038

Instituto Nacional de Enfermedades Neoplásicas ( Site 1251), Lima

15072

Hospital Nacional Edgardo Rebagliati Martins ( Site 1250), Lima

37126

Azienda Ospedaliera Universitaria Integrata ( Site 1151), Verona

60611

Ann & Robert H. Lurie Children's Hospital of Chicago ( Site 1402), Chicago

63110

Washington University ( Site 1403), St Louis

64460

"Hospital Universitario Dr. Jose Eleuterio Gonzalez-Infectologia ( Site 1204)", Monterrey

92123

Rady Children's Hospital-San Diego ( Site 1401), San Diego

92868

Children's Hospital of Orange County ( Site 1409), Orange

117198

Dmitry Rogachev National Research Center ( Site 1275), Moscow

194291

Institute of Invasive Mycosis ( Site 1282), Saint Petersburg

197022

Institute of Child Hematology and Transpl n.a.R.M.Gorbacheva ( Site 1281), Saint Petersburg

197341

Almazov National Medical Research Centre ( Site 1284), Saint Petersburg

3525408

Rambam Medical Center ( Site 1125), Haifa

5262100

Chaim Sheba Medical Center ( Site 1126), Ramat Gan

6423906

Sourasky Medical Center ( Site 1128), Tel Aviv

9112001

Hadassah Ein Karem Hebrew University Medical Center ( Site 1127), Jerusalem

115 27

Athens Childrens Hospital Aglaia Kyriakou ( Site 1052), Athens

546 36

"University General Hospital of Thessaloniki AHEPA ( Site 1053)", Thessaloniki

546 42

"General Hospital of Thessaloniki Ippokrateio ( Site 1050)", Thessaloniki

04530

Instituto Nacional de Pediatria ( Site 1200), Mexico City

03080

Seoul National University Hospital ( Site 1326), Seoul

06591

The Catholic University of Korea. Seoul St. Mary s Hospital ( Site 1325), Seoul

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT04218851 - Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104) | Biotech Hunter | Biotech Hunter